Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Neurocognitive function after WBRT plus SRS or SRS alone.

Weiss SE, Kelly PJ.

Lancet Oncol. 2010 Mar;11(3):220-1. doi: 10.1016/S1470-2045(09)70387-0. No abstract available.

PMID:
20202605
2.

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA.

Lancet Oncol. 2009 Nov;10(11):1037-44. doi: 10.1016/S1470-2045(09)70263-3. Epub 2009 Oct 2.

PMID:
19801201
3.

Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1388-95.

PMID:
17674975
4.

Whole-brain irradiation for patients with brain metastases: still the standard of care.

Mahmood U, Kwok Y, Regine WF, Patchell RA.

Lancet Oncol. 2010 Mar;11(3):221-2; author reply 223. doi: 10.1016/S1470-2045(09)70389-4. No abstract available.

PMID:
20202606
5.

Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.

Lester-Coll NH, Dosoretz AP, Yu JB.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):563-8. doi: 10.1016/j.ijrobp.2014.03.001. Epub 2014 Apr 18.

PMID:
24751412
6.

Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.

Brown PD, Asher AL, Farace E.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1305-9. doi: 10.1016/j.ijrobp.2007.11.047. Epub 2008 Jan 30. Review.

PMID:
18234426
7.

Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.

Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Neyman G, Reuther AM, Suh JH.

Cancer. 2008 Oct 15;113(8):2198-204. doi: 10.1002/cncr.23821.

8.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
9.

Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.

Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR 4th, Lieberson RE, Soltys SG.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):336-42. doi: 10.1016/j.ijrobp.2011.12.009. Epub 2012 May 30.

PMID:
22652105
10.

Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.

Monaco EA 3rd, Faraji AH, Berkowitz O, Parry PV, Hadelsberg U, Kano H, Niranjan A, Kondziolka D, Lunsford LD.

Cancer. 2013 Jan 1;119(1):226-32. doi: 10.1002/cncr.27504. Epub 2012 Jun 15.

11.

Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.

Do L, Pezner R, Radany E, Liu A, Staud C, Badie B.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):486-91. doi: 10.1016/j.ijrobp.2008.04.070. Epub 2008 Oct 14.

PMID:
18922650
12.

Focused attention on brain metastases.

Knisely JP.

Lancet Oncol. 2009 Nov;10(11):1024. doi: 10.1016/S1470-2045(09)70320-1. No abstract available.

PMID:
19880055
13.

Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.

Minniti G, Salvati M, Muni R, Lanzetta G, Osti MF, Clarke E, Costa A, Bozzao A, Trasimeni G, Enrici RM.

Anticancer Res. 2010 Jul;30(7):3055-61.

PMID:
20683055
14.
15.

Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.

Kong DS, Lee JI, Im YS, Nam DH, Park K, Kim JH.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):385-9. doi: 10.1016/j.ijrobp.2009.08.027. Epub 2010 Jan 25.

PMID:
20097485
16.

Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy.

Hsu F, Kouhestani P, Nguyen S, Cheung A, McKenzie M, Ma R, Toyota B, Nichol A.

Radiother Oncol. 2013 Jul;108(1):128-31. doi: 10.1016/j.radonc.2013.04.025. Epub 2013 Jun 3.

PMID:
23742960
17.

Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.

Patil CG, Pricola K, Garg SK, Bryant A, Black KL.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006121. doi: 10.1002/14651858.CD006121.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD006121.

PMID:
20556764
18.

Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.

Chidel MA, Suh JH, Greskovich JF, Kupelian PA, Barnett GH.

Radiat Oncol Investig. 1999;7(5):313-9.

PMID:
10580901
19.

Strategies for preservation of memory function in patients with brain metastases.

Dye NB, Gondi V, Mehta MP.

Chin Clin Oncol. 2015 Jun;4(2):24. doi: 10.3978/j.issn.2304-3865.2015.05.05. Review.

20.

A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.

Rades D, Kueter JD, Pluemer A, Veninga T, Schild SE.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1077-81. doi: 10.1016/j.ijrobp.2008.05.035. Epub 2008 Aug 15.

PMID:
18707817

Supplemental Content

Support Center